TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Schimmer Roman R; Kovtonyuk Larisa V; Klemm Nancy; Fullin Jonas; Stolz Sebastian M; Mueller Jan; Caiado Francisco; Kurppa Kari J; Ebert Benjamin L; Manz Markus G; Boettcher Steffen
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Schimmer Roman R
Kovtonyuk Larisa V
Klemm Nancy
Fullin Jonas
Stolz Sebastian M
Mueller Jan
Caiado Francisco
Kurppa Kari J
Ebert Benjamin L
Manz Markus G
Boettcher Steffen
Katso/Avaa
Lataukset: 

Elsevier
doi:10.1182/bloodadvances.2021005859
URI
https://doi.org/10.1182/bloodadvances.2021005859
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2022091559191
Kokoelmat